These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6758743)

  • 1. Anti-hypertensive action of labetalol: a detailed profile.
    Bellamy GR; Hunyor SN; Roffe D; Massang J
    Aust N Z J Med; 1982 Oct; 12(5):467-72. PubMed ID: 6758743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnitude and mechanisms of the antihypertensive action of labetalol, including ambulatory assessment.
    Bellamy GR; Hunyor SN; Roffe D; Massang J
    Br J Clin Pharmacol; 1983 Jul; 16(1):9-16. PubMed ID: 6882628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of an alpha- and beta-adrenoceptor-blocking agent (labetalol) on haemodynamics in hypertension.
    Bahlmann J; Brod J; Hubrich W; Cachovan M; Pretschner P
    Br J Clin Pharmacol; 1979; 8(Suppl 2):113S-117S. PubMed ID: 526390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of labetalol in hypertension during exercise and postural changes.
    Balasubramanian V; Mann S; Millar-Craig MW; Raftery EB
    Br J Clin Pharmacol; 1979; 8(Suppl 2):95S-100S. PubMed ID: 526410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic effects of labetalol, an alpha and beta adrenergic blocking agent, in hypertensive subjects.
    Mehta J; Cohn JN
    Circulation; 1977 Feb; 55(2):370-5. PubMed ID: 12880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A controlled trial of labetalol (Trandate), propranolol and placebo in the management of mild to moderate hypertension.
    Pugsley DJ; Nassim M; Armstrong BK; Beilin L
    Br J Clin Pharmacol; 1979 Jan; 7(1):63-8. PubMed ID: 367410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
    Wong GW; Laugerotte A; Wright JM
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Labetalol and propranolol in mild hypertensives: comparison of blood pressure and plasma volume effects.
    Hunyor SN; Bauer GE; Ross M; Larkin H
    Aust N Z J Med; 1980 Apr; 10(2):162-6. PubMed ID: 6930206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Action of labetalol on heart rate, arterial pressure and systolic time intervals at rest and during exercise in hypertensive subjects].
    Cherchi A; Raffo M; Sau F; Seguro C; Pirisi R
    Boll Soc Ital Cardiol; 1978; 23(1):158-76. PubMed ID: 754770
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of labetalol versus enalapril as monotherapy in elderly patients with hypertension: results of 24-hour ambulatory blood pressure monitoring.
    Applegate WB; Borhani N; DeQuattro V; Kaihlanen PM; Oishi S; Due DL; Sirgo MA
    Am J Med; 1991 Feb; 90(2):198-205. PubMed ID: 1996588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
    Prichard BN
    Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interdose control of beta-blockade and arterial blood pressure during chronic oral labetalol treatment.
    Sanders GL; Murray A; Rawlins MD
    Br J Clin Pharmacol; 1979; 8(Suppl 2):125S-127S. PubMed ID: 43163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of labetalol on continuous ambulatory blood pressure.
    Balasubramanian V; Mann S; Raftery EB; Millar-Craig MW; Altman D
    Br J Clin Pharmacol; 1979; 8(Suppl 2):119S-123S. PubMed ID: 526391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Essential arterial hypertension. Effects of labetalol on blood pressure and renin-angiotensin system (author's transl)].
    Martinand A; Lardoux H; Corvol P; Milliez P
    Nouv Presse Med; 1980 Sep; 9(35):2565-8. PubMed ID: 7001349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of exercise on intra-arterial blood pressure and pulse rate before and during long-term high-dose treatment with labetalol in patients with severe, therapy-resistant hypertension.
    la Cour Petersen E; Kristensen BO
    Postgrad Med J; 1980; 56 Suppl 2():60-4. PubMed ID: 7433345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative effects of an alpha 1 and beta 1-2 blocker (labetalol) and a beta-1 blocker (atenolol) in the hypertensive patient].
    Sassard J; Zech PY; Pozet N; Cuisinaud G; Vincent M
    J Pharmacol; 1983; 14 Suppl 2():121-9. PubMed ID: 6355664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind trial of labetalol.
    Kane J; Gregg I; Richards DA
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):737-41. PubMed ID: 791329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monotherapy with labetalol for hypertensive patients with normal and impaired renal function.
    Thompson FD; Joekes AM; Hussein MM
    Br J Clin Pharmacol; 1979; 8(Suppl 2):129S-133S. PubMed ID: 526392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience with labetalol in hypertension.
    Bolli P; Waal-Manning J; Wood AJ; Simpson FO
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):765-71. PubMed ID: 791330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hypotensive effect and changes of arterial pressure variability induced by treatment with labetalol in patients with slight and moderate arterial hypertension].
    Palatini P; Pessina AC; Sperti G; Ventura E; Agnoletto V; Semplicini A; Hlede M; Gava R; Mormino P; Dal Palù C
    G Ital Cardiol; 1983; 13(1):18-22. PubMed ID: 6873535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.